(ĐTĐ) - The popular supplement glucosamine doesn't help people who have low back pain, a clinical trial finds.

The study looked specifically at 250 people with evidence of osteoarthritis (OA) of the spine. All of the patients had at least some disability because of low back pain, but most were still able to work.

For six months, half the patients got 1,500-milligram daily doses of glucosamine sulfate and half got inactive placebo pills, notes study leader Philip Wilkens, MChiro, a research fellow at Norway's Oslo University.

"There was no benefit of glucosamine compared to placebo," Wilkens tells WebMD. "You would get the same result from taking sugar pills as taking the real deal."

On average, patients in both the glucosamine and placebo groups had less back pain and less disability after six months of treatment, and for six months after the end of the study.

Why did both groups improve? Part of the improvement is the placebo effect. That's the natural tendency of people to feel better when they believe they are being treated. But part of the reason is that patients come to treatment, and to clinical trials, when their condition is at its worst.

"People feel worse when they volunteer. That is a bad period, and it is usually followed by a good period. It's sort of a natural development of the condition of low back pain," Wilkens says.

Glucosamine for Low Back Pain: Worth a Try?

In osteoarthritis, cartilage in the joints degenerates. Glucosamine is a building block for the molecules from which cartilage is made. The theory behind glucosamine supplements is that taking them will slow or reverse cartilage degeneration.

It's a popular theory. According to the supplement industry group Council for Responsible Nutrition (CRN), 7% of Americans take glucosamine and/or chondroitin, a component of cartilage usually derived from animal or fish cartilage.

And in an editorial accompanying the Wilkens study, Kaiser-Permanente researcher Andrew Avins, MD, MPH, notes that 25% of people with low back pain have tried glucosamine supplements.

Even so, glucosamine is usually taken for knee osteoarthritis, says Andrew Shao, PhD, CRN senior vice president for scientific and regulatory affairs. Shao notes that low back pain can be caused by a number of things besides osteoarthritis.

"I know the researchers had to include some patients who had some degenerative joint issues in the back, but low back pain is a very broad kind of term. There can be a lot of reasons people experience it," Shao tells WebMD. "It is a tall order for something to affect such a global condition."

Shao says it would be premature to conclude that glucosamine has no benefit for any patients with spinal osteoarthritis. But that's pretty much the take-home message from the study, Avins suggests.

"No one study settles any question, but this study does not make glucosamine look promising for low back pain at this point," Avins tells WebMD.

Wilkens says that although his study found glucosamine had no effect on chronic low back pain, it did no harm. And some patients who improved while taking the supplement told him they were sure it helped them.

"If as an individual you feel glucosamine is the drug for you, there is no harm in taking it except for the expense," he says. "If you want to try, go ahead -- but I would not rely on it as the sole means of reducing your low back ache."

Might there be a subgroup of patients for whom glucosamine truly does help low back pain? Wilkens says that his team was unable to identify such patients based on pre-treatment MRI scans or on demographic factors.

But Shao notes that no MRI scans were taken after treatment, so there's no way to know whether patients' osteoarthritis had begun to improve while on treatment.

Avins laments that while low back pain is a huge health problem, it gets scant research attention.

"We will spend $100 billion this year on treatments related to low back pain, and most don't work," Avins says. "We spend such a tiny, tiny fraction of this on looking into the kinds of treatments that might give us the benefits we seek. It is frustrating."

The Wilkens study, and the Avins editorial, appear in the July 7 issue of the Journal of the American Medical Association. Neither reports any financial conflicts of interest, and the Wilkens study received no industry support. Study medication was purchased after all companies with glucosamine marketing approval in Norway were asked if they wanted to contribute their products.

WebMD Health News - Source WemMD.com
Gout - Definition, Diagnosis and Treatment
09 Dec 2017 11:05 - VNPainGout - Definition, Diagnosis and Treatment

DEFINITION Gout is a term used to refer to a group of disease states caused by tissue deposition of monosodium urate due to prolonged hyperuricemia. Clinical manifestations of gout include acu [ ... ]

A National Campaign Calls for Investment in Pain Research and Access to Pain Therapies- Pain News
08 Sep 2016 02:35 -

By Ed Coghlan The nation’s largest pain patient advocacy group has launched a campaign called “People With Pain Matter”. The U.S. Pain Foundation wants to  raise public awareness of the impact  [ ... ]

Children and Pain: Acupuncture Provides Pain Relief for Kids with Chronic Conditions- Pain News
08 Sep 2016 02:35 -

By Staff Acupuncture appears to be an effective pain management tool for children who have chronic medical conditions, according to a study published by Gillette Children’s Specialty Healthcare. Th [ ... ]

FDA Approves Biologic Drug to Treat Several Forms of Arthritis, Ankylosing Spondylitis and Plaque Ps...
08 Sep 2016 02:35 -

By Staff People who suffer from Rheumatoid Arthritis, Psoriatic Arthritis, Ankylosing Spondylitis and Plaque Psoriasis just got some good news:  A new drug called Erelzi just received FDA approval to [ ... ]

How Our Stuff Might Be Making Us Sicker- Pain News
08 Sep 2016 02:35 -

Donna Gregory Burch Lately I’ve been wondering if our material possessions could play a role in our fibromyalgia symptoms. My ruminating started a few months ago when the KonMari craze was at its pe [ ... ]

My Passion for Distraction- Pain News
08 Sep 2016 02:35 -

By Cynthia Toussaint I’ve been using distraction as my #1 painkiller for 34 years without knowing it. Now that I’ve come to  understand the power of intuitive healing, I want to shout it to the w [ ... ]

A Mother/Daughter/Advocate On Why She Fights for Chronic Pain Patients- Pain News
31 Aug 2016 07:24 -

By Ed Coghlan Terri Lewis, PhD is another chronic pain advocate that is working to make a difference for people like her son, who suffers from chronic pain. The National Pain Report asked her for a fe [ ... ]

DEA Moves on Kratom Classification- Pain News
31 Aug 2016 07:24 -

by Ed Coghlan The Drug Enforcement Administration (DEA) is continuing to try and squeeze what it believes are addictive drugs and properties.  Today it announced its intention to place the active mat [ ... ]

New Direction for Painkiller Research: Target Opioid Receptors Outside of the Brain to Reduce Side E...
31 Aug 2016 07:24 -

By Staff There may be a new direction in the development of opioid medication after researchers discover a different target for opioid receptors in the brain.  Most opioid pain medications target wha [ ... ]

Opiate Tolerance – FACT OR FICTION- Pain News
31 Aug 2016 07:24 -

By Steve Ariens, Ph.D. We often hear about chronic pain patients need to increase their dosage because of tolerance to their medication(s). Many of the people that put out all these “facts” tend t [ ... ]

Relief for Stroke Survivors with Shoulder Pain- Pain News
31 Aug 2016 07:24 -

By Ed Coghlan Up to 85% of stroke survivors suffer from chronic shoulder pain and that pain often stops them from continuing their efforts to rehabilitate after their stroke. When a stroke survivor ca [ ... ]

A Loved One’s Advocacy to Fight Chronic Pain- Pain News
23 Aug 2016 01:58 -

By Ed Coghlan Since we founded the National Pain Report, we’ve met a number of people whose loved ones suffer from chronic pain and advocate for them and the millions of others. One of them is retir [ ... ]

Midwest Pain Treatment Education Expo-Big Dreams Come to Life- Pain News
23 Aug 2016 01:58 -

By Gracie Bagosy-Young Editor’s Note- Saturday August 13, the Midwest Pain Treatment Education Expo was held near Chicago. It started three years ago as an idea by chronic pain activist Gracie Bagos [ ... ]

Researchers Create “Unprecedented, Weird and Cool” Opioid Painkiller from Scratch- Pain News
23 Aug 2016 01:58 -

By Staff Researchers from U.C. San Francisco, Stanford University, the University of North Carolina and the Friedrich-Alexander University Erlangen-Nürnberg have cooked up a new opioid drug candidate [ ... ]

3rd Annual US Pain Summit- Pain News
19 Aug 2016 07:23 -

By Katie M. Golden Making your way in the world today Takes everything you’ve got; Taking a break from all your worries Sure would help a lot. Wouldn’t you like to get away? Sometimes you want to  [ ... ]

Research Finds Link Between Dry Eyes and Chronic Pain- Pain News
19 Aug 2016 07:23 -

By Tara Heath Dry eye is a medical condition suffered by those whose eyes either don’t produce sufficient tears or they are of poor quality. Without sufficient lubrication for these eyes, they are a [ ... ]

Scientists Target Brain Cells to Alleviate Neuropathic Pain- Pain News
19 Aug 2016 07:23 -

By Staff More than one million Americans have neuropathic pain. Wouldn’t it be a good thing if that pain could be reduced or even eliminated? Scientists at Rutgers University think that targeting br [ ... ]

Why Are You Stiff in the Morning? New Discovery May Help Improve Treatment of Painful Inflammatory D...
19 Aug 2016 07:23 -

By Staff A protein created by the body’s “biological clock” (circadian) that actively represses inflammatory pathways during the night is responsible for that stiffness many feel in the morning, [ ... ]

DEA Doesn’t Budget on Marijuana Classification but Relents (A little) on Research- Pain News
14 Aug 2016 07:46 -

By Ed Coghlan If the medical benefits of marijuana are going to be approved by the federal government, it won’t happen while Barack Obama is President. The Drug Enforcement Administration declared m [ ... ]

Last Day to Sign the National Pain Strategy Petition- Pain News
14 Aug 2016 07:46 -

By Ed Coghlan Friday August 12 is the deadline to sign a petition that urges the White House to direct the Department of Health and Human Services to fund the National Pain Strategy. (To Sign The Peti [ ... ]

Other Articles

Comments